Rheumatology Flashcards

(143 cards)

1
Q

Causes of low back pain

A
  • Mechanical (soft-tissue lesion) back pain
  • Intervertebral disc lesions (e.g. prolapse, disc degeneration)
  • Facet joint disease (osteoarthritis, psoriatic arthritis)
  • Vertebral fracture
  • Paget’s disease
  • Axial spondyloarthritis
  • Spondylodiscitis
  • Spondylolisthesis
  • Bone metastases
  • Scheuermann’s disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Features of mechanical low back pain

A
  • Time:
    • Often sudden
    • Recurrent episodes
  • Factors:
    • Precipitated by lifting or bending
    • Pain varies with physical activity (improved with rest)
  • Site: Limited to back or upper leg
  • No clear-cut nerve root distribution
  • No systemic features
  • Prognosis good (90% recovery at 6 weeks)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Back pain >>> Red flags for possible spinal pathology

A

History:

  • Age: presentation < 20 years or > 55 years
  • Character: constant, progressive pain unrelieved by rest
  • Location: thoracic pain
  • Past medical history:
    • Carcinoma
    • Tuberculosis
    • HIV
    • Systemic glucocorticoid use
    • Osteoporosis
  • Constitutional: systemic upset, sweats, weight loss (B symptoms like)
  • Major trauma

Examination:

  • Painful spinal deformity
  • Severe/symmetrical spinal deformity
  • Saddle anaesthesia
  • Progressive neurological signs/muscle-wasting (neurological)
  • Multiple levels of root signs (neurological)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Clinical features of radicular pain

A

Clinical features of radicular pain

  • Nerve root pain
  • Unilateral leg pain worse than low back pain
  • Pain radiates beyond knee
  • Paraesthesia in same distribution
  • Nerve irritation signs (reduced straight leg raising that reproduces leg pain)
  • Motor, sensory or reflex signs (limited to one or adjacent nerve roots)
  • Prognosis reasonable (50% recovery at 6 weeks)

Cauda equina syndrome

  • Difficulty with micturition
  • Loss of anal sphincter tone =/ faecal incontinence
  • Saddle anaesthesia
  • Gait disturbance
  • Pain, numbness or weakness affecting one or both legs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Clinical assessment of back pain

A

The main purpose: To differentiate the self-limiting disorder of acute mechanical back pain from serious spinal pathology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Mechanical back pain >>> frequency

A
  • It is the most common cause of Acute back pain in aged 20–55 >>> accounts for more than 90% of episodes
  • Low back pain is more common in → manual workers
    • Particularly those involve heavy lifting and twisting.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How to assess mechanical back pain

A
  • Presentation:
    • It is usually Acute
    • Associated with >>> lifting or bending.
    • Exacerbated by >> activity
    • Relieved by >>> rests
    • confined to the lumbar–sacral region, buttock or thigh
    • Asymmetrical
    • Does not radiate beyond the knee (which would imply nerve root irritation)
  • O/E:
    • Asymmetrical
    • Local paraspinal muscle spasm
    • Tenderness
    • Painful restriction of some, but not all, movements.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Mechanical back pain >>> prognosis

A
  • Generally good
  • After 2 days >>> 30% are better
  • By 6 weeks >>> 90% have recovered
  • Recurrences of pain may occur
  • About 10–15% of patients >>> go on to develop chronic back pain >>> that may be difficult to treat.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Factors that may cause transition of acute mechanical back pain to a chronic pain

A

Psychological elements, such as

  • job dissatisfaction
  • Depression
  • Anxiety
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Back pain secondary to serious spinal pathology (Not mechanical) ⇒

Urgent investigation is needed if there is - ?

A
  • clinical evidence of spinal cord or nerve root compression
  • sepsis including tuberculosis, or
  • a cauda equina lesion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Spinal stenosis >>> presentation

A
  • Presents insidiously
  • Leg discomfort on walking
  • Relieved by >>>
    • Rest
    • Bending forwards (Thus may be more area is formed within)
    • Walking uphill
  • May adopt characteristic simian posture, with >>>
    • Forward stoop + slight flexion at hips and knees.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Spinal stenosis >>> the most common cause

A

The most common cause is:

Gadual development of coexisting contributing lesions such as >>>

  • Facet joint arthritis
  • Ligament flavum thickening or
  • Degenerative spondylolisthesis.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Degenerative disc disease is more common in -?

A

It is a common cause of chronic low back pain in middle-aged adults.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Prolapsed intervertebral disc >>> presentation

A

Prolapse of an intervertebral disc presents when >>> discs are still well hydrated

  • Young and early middle age >>> nerve root pain
  • Can be accompanied by >>>
    • A sensory deficit
    • Motor weakness
    • Asymmetrical reflexes
  • Examination may reveal > positive sciatic or femoral stretch test.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Prolapsed intervertebral disc >>> prognosis

A

About 70% of patients improve by 4 weeks.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Inflammatory back pain (IBP) >>> 2 important causes

A
  • Axial spondyloarthritis (axSpA)
  • Psoriatic arthrits (PsA)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Inflammatory back pain >>> presentations

[due to axial spondyloarthritis (axSpA) &

Psoriatic arthrits (PsA)]

A
  • Gradual onset
  • Almost always before the age of 40
  • Associated with morning stiffness
  • Improves with movement
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Spondylolisthesis >>> presentation

A
  • Back pain
  • Typically aggravated by standing and walking

Occasionally, diffuse idiopathic skeletal hyperostosis >>>>> can cause back pain but it is usually asymptomatic.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Arachnoiditis

A

Rare cause of chronic severe low back pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Arachnoiditis >>> cause

A
  • Chronic inflammation of the nerve root sheaths in the spinal canal >>> further, can complicate meningitis
  • Spinal surgery or
  • Myelography with oil-based contrast agents.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

When is investigation needed in back pain?

A
  • Acute mechanical back pain > No investigation required
  • Persistent pain (> 6 weeks) OR red flags >>> need further investigation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Back pain >>> Investigation of choice (IOC)

A

MRI (Magnetic resonance imaging)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

In back pain, MRI is the IOC >>> because?

A

Because, it can demonstrate >>>

  • spinal stenosis
  • cord compression
  • nerve root compression
  • inflammatory changes in axSpA
  • sepsis
  • malignancy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Investigations of back pain >>> imgaing modalities

A
  • MRI (MAgnetic resonance imaging) >>> IOC
  • Plain X-ray
  • Bone scintigraphy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Indications of 'plain X-ray' in back pain
* Suspected vertebral compression fractures * OA (Osteroarthritis) * Degenerative _disc_ disease
26
Indication of bone scintigraphy in back pain
If metastatic disease is suspected
27
Back pain \>\>\> additional investigations
* Routine biochemistry * CBC *(= haematology)* * ESR * CRP (to screen for sepsis and inflammatory disease) * Protein and urinary electrophoresis \>\>\> for myeloma * HLA-B27 status \>\>\> in IBP * PSA \>\>\> for prostate carcinoma
28
Pateint with low back pain \>\>\> indications of surgery
* _Progressive_ spinal stenosis * Spinal cord compression _with_ nerve root compression
29
Management of back pain
* **Education** is important in mechanical back pain. Eemphasise \>\>\> * It is self-limiting condition * Exercise is helpful (rather than damaging) * Regular **Analgesia and/or NSAIDs** (may be required) \>\>\> to improve mobility + to facilitate exercise. * **Return to work** and normal activity (ASAP) * Bed rest is NOT helpful \>\>\> may increase the risk of chronic disability. * If a return to normal activities has not been achieved by 6 weeks \>\>\> refer for **physical therapy** * **Low-dose tricyclic antidepressant** \>\>\> may help pain, sleep and mood. Other occasional treatment modalities \>\>\> * Epidural and facet joint injection * Traction * Lumbar supports *(though there is limited RCT evidence to support their use)* * Malignant disease, osteoporosis, Paget’s disease and SpAs \>\>\>\>\> specific treatment of the underlying condition. * Surgery is required in less than 1% of patients with low back pain
30
Osteoarthritis: epidemiology
* The prevalence rises progressively with age * At some point of life \>\>\> 45% of all people develop knee OA and 25% hip OA * Although some are asymptomatic \>\>\>\>\> the lifetime risk of having a total hip or knee replacement for OA in someone aged 50 is about 11% for women and 8% for men in the UK. * There are major ethnic differences in susceptibility: * The prevalence of hip OA is lower in Africa, China, Japan and the Indian subcontinent than in European countries, and that of knee OA is higher. * Higher prevalence of knee OA in the Indian subcontinent and East Asia might be accounted for _by squatting._
31
Osteoarthritis: Risk factors
**Genetics** • Skeletal dysplasias • Polygenic inheritance (in most cases \> polygenic; several genetic variants of small effects) * Heritability of OA ranges from \>\>\> * *_Knee \> 43%_* * *_Hip \> 60%_* * *_Hand \> 65%_* * OA can, however, be a component of _multiple epiphyseal dysplasias_ \>\>\>\>\> caused by mutations in the genes that encode components of _cartilage matrix._ **Developmental abnormalities (/structural abnormalities) Cause:**presumably due to \>\>\> abnormal load distribution across the joint • _Developmental dysplasia_ of the hip • _Slipped femoral epiphysis_ \>\>\> these are associated with a high risk of OA (Similar mechanisms probably explain the increased risk of OA in patients with limb deformity secondary to Paget’s disease of bone) **Repetitive loading (due to 'biomechanical factors')** • Farmers \>\>\> hip OA • Miners \>\>\> knee OA • Elite or pofessional athelets \>\>\> knee or ankle OA **Adverse biomechanics (who have had destabilising injuries)** • Meniscectomy • Ligament rupture • Paget’s disease **Obesity** (strong association) * Particularly hip \>\>\> thought to be,partly due to \>\>\> * biomechanical factors * (also play a role) _cytokines_ released from adipose tissue **Trauma Hormonal**(_Oestrogen_ appears to play a role) • Oestrogen deficiency • Aromatase inhibitors *(for therapy of breast cancer)* \>\>\> flare of OA symptoms **Neutral factor:** Participation in recreational sport \>\>\> does not increase risk significantly **Protective factor:** HRT; \>\>\> women who use HRT have lower rates of OA
32
Osteoarthritis: main pathological process
* **Defining feature of OA:** degenation of articular cartilage * **Normally,** chondrocytes are terminally differentiated cells * **In OA** \>\>\> chondrocytes start dividing to produce \>\>\> "nests of metabolically active cells" * **Initially,** matrix components are produced by these cells (at an increased rate) * **At the same time** \>\>\> accelerated degradation of the major structural components of cartilage matrix, including _aggrecan_ _and type II collagen_ * **Eventually,** the concentration of aggrecan in cartilage matrix falls \>\>\> makes the cartilage vulnerable to load-bearing injury \>\>\> fissuring of the cartilage surface (‘fibrillation’) then occurs \>\>\> leading to \>\> * the development of deep vertical clefts * localised chondrocyte death * decreased cartilage thickness. ## Footnote \>\>\>This is initially focal \>\>\> mainly targeting the maximum load-bearing part of the joint \>\>\> But eventually \> large parts of the cartilage surface are damaged \>\>\> in the abnormal cartilage, _c__alcium pyrophosphate and basic calcium phosphate crystals_ often become deposited
33
Osteoarthritis: defining feature
degenation of articular cartilage
34
Osteoarthritis: pathology in sub-chondral bone
Abnormalities in subchondral bone \>\>\> * sclerotic * the site of subchondral cysts
35
Osteoarthritis \>\>\> joint margin
At the joint margin \>\>\> fibrocartilage is produced \>\>\> undergoes endochondral ossification \>\> form osteophytes
36
Osteoarthritis \>\>\> shape
* Bone remodelling + cartilage thinning \>\>\> slowly alter the shape of the OA joint \>\>\> _increasing its surface area._ * Homeostatic mechanism operative in OA \>\>\> causes \> enlargement of the failing joint \>\>\> to spread the mechanical load over a greater surface area.
37
Osteoarthritis \>\>\> BMD and osteoporosis
* Higher BMD values (at sites distant from the joint) + particularly, associated with osteophyte formation. * Patients with OA are partially protected from developing osteoporosis and vice versa. * Why: the genetic factors that predispose to osteoporosis might be protective for OA.
38
Osteoarthritis \>\>\> the synovium
* in OA \>\>\> the synovium is often **hyperplastic** * It may be the site of **inflammatory change** * But to a much lesser extent than in RA &other inflammatory arthropathies. * **Osteochondral bodies** commonly occur within the synovium, reflecting \>\>\> * chondroid metaplasia or * secondary uptake and growth of damaged cartilage fragments
39
Osteoarthritis \>\>\> the outer capsule
Outer capsule also thickens and contracts \>\>\> usually retaining the stability of the remodelling joint.
40
Osteoarthritis \>\>\> surrounding muscles
Around the joints \>\>\> wasting of muscles + non-specific type II fibre atrophy
41
Osteoarthritis \>\>\> Clinical features (signs & symptoms)
* *Main presenting symptoms:** joint pain + functional restriction * *Characteristic distribution:** the hips, knees, PIP and _DIP_ joints of the hands, neck and lumbar spine **Pain** * **Onset**: insidious \>\>\> over months or years * **Nature:** Variable or intermittent nature over time (‘good days, bad days’) * **Mainly related to/increased by** \>\>\> movement and weight-bearing * **Releived by** \>\>\> Rest * _Only brief (\<15 mins) morning stiffness and brief (\<5 mins) ‘gelling’ after rest_ * _Usually only one or a few joints painful_ **Clinical signs** * **Restricted movement** * For many people, functional restriction of the hands, knees or hips is an equal, if not greater, problem than pain * **Coarse crepitus:** _Palpable, sometimes audible_ * **Bony swelling** (_Around joint margins_) * **Tenderness** (_Joint-line or periarticular_) * **Deformity** (usually _without instability_) * **Muscle weakness and wasting** * *Mild or absent synovitis* * The clinical findings _vary according to severity_ but are *principally* *those of joint damage.*
42
Osteoarthritis \>\>\> cause of joint pain
The causes of pain in OA are not completely understood but may relate to \>\>\> * _increased pressure_ in **subchondral bone** (mainly causing _night pain)_ * **Trabecular** _microfractures_ * **Capsular** _distension_ * **Synovium** \>\>\> _Low-grade synovitis_ * Bursitis (may also be) * Enthesopathy (Secondary to altered joint mechanics) (may also be)
43
Coarse crepitus in OA (palpable +/- audible) \>\>\> cause?
Rough articular surfaces
44
Restricted movement in OA \>\>\> cause?
due to capsular thickening or blocking by osteophyte
45
Osteoarthritis \>\>\> the correlation between structural changes (assessed by imaging) & clinical features
The correlation between the presence of structural change (as assessed by imaging, and symptoms such as pain and disability) **Varies markedly according to site.** The correlation \>\>\> * **Stronger at the hip (than that of knee)** * **Poor at small joints** This suggests that \>\>\> the risk factors for pain and disability may differ from those for structural change. \>\>\>\> for example \>\>\> * **At the knee,** \>\>\>\>\> reduced quadriceps muscle strength + adverse psychosocial factors (anxiety, depression) \>\>\>\> correlate more strongly with pain and disability [[than the degree of radiographic change]] * _Radiological evidence_ of OA is _very common in middle-aged_ _and older people_ * The disease may coexist with other conditions, \>\>\> so it is important to remember that \>\>\> pain in a patient with OA may be due to another cause.
46
Generalised nodal OA: characteristics
* **Age:** Peak onset in the middle age * **Sex:** Marked female preponderance * **Genetics:** Strong genetic predisposition; * the daughter of an affected mother has a 1 in 3 chance of developing nodal OA herself. * **In hand:** * Polyarticular \>\>\> finger interphalangeal joint OA * Heberden’s (± Bouchard’s) nodes * _Good functional outcome for hands_ * Predisposition to OA at other joints, _especially knees_
47
Generalised nodal OA \>\>\> course of the disease
Some patients are _asymptomatic_ ..... whereas, others \>\>\> **From 40 years onwards** \>\>\> at **one or more PIP and DIP joints** of the hands \>\>\> _pain +_ _stiffness + swelling_ \>\>\> gradually, these develop _posterolateral swellings_ *on each side of the* *_extensor tendon_* \>\>\> which slowly _enlarge + harden_ \>\> become **Heber**_d_**en’s (**_D_**IP)** and **Bouchard’s (PIP)** nodes. Typically, **Each joint** \>\>\> goes through *_a phase of episodic symptoms_* *_(1–5 years)_* \>\>\> while _the node evolves and OA develops_ \>\>\> **Once OA** **is fully established** \>\>\> * *Symptoms may subside + hand function often remains good* * Due to _osteophyte_ formation \>\>\> affected _joints are enlarged_ * characteristic lateral deviation (often showed) \>\>\> reflecting the asymmetric focal cartilage loss of OA
48
If generalised nodal OA involves first CMC (Carpo-metacarpal) joint \>\>\> Sign and symptoms
Involvement of the first CMC joint is also common, leading to \>\>\> * Pain on trying to open bottles and jars * Functional impairment Clinically, it may be detected by \>\>\> * The presence of crepitus on joint movement, and * Squaring of the thumb base
49
Targeted area in Knee OA
At the knee, OA principally targets \>\>\> * the patello-femoral compartment * the medial tibio-femoral compartments But eventually spreads \>\>\> to affect the whole of the joint It may be \>\>\> * Part of generalised nodal OA or isolated OA * Most patients have bilateral and symmetrical involvement.
50
Knee OA \>\>\> important risk factor in men
Trauma \>\>\> may cause unilateral OA
51
Knee OA \>\>\> symptoms
* **Localised pain** \>\>\> in the anterior or medial aspect of the knee and upper tibia. * **Patello-femoral pain** \>\>\> (usually) worse going up and down stairs or inclines. * **If posterior** **knee pain** \>\>\> suggests \>\>\> the presence of a complicating popliteal cyst (Baker’s cyst). * Difficulties in tasks, such as: * Prolonged walking * Rising from a chair * Getting in or out of a car * Bending to put on shoes and socks
52
Knee OA \>\>\> signs (local examination findings)
* **Gait:** A jerky, asymmetric (antalgic) gait + less time weightbearing on the painful side * **Deformity:** * Varus * Valgus (less commonly) * (and/or) fixed flexion deformity * **Tenderness:** * Joint-line and/or periarticular tenderness (_secondary anserine bursitis + medial ligament enthesopathy_) \>\>\> causing tenderness of the _upper medial tibia_ * **Weakness and wasting** of the _quadriceps muscle_ * **Restricted flexion and extension** + **coarse crepitus** * **Bony swelling** _around the joint line_ * **In knee OA \>\>\> CPPD crystal deposition is common** * *This may result in** \>\>\> more _overt inflammatory component (stiffness, effusions)_ + _super-added acute attacks of synovitis_ \>\>\> which may be associated with \>\>\> *more rapid radiographic and clinical progression*
53
Osteoarthritis \>\>\> investigations
* A **Plain X-ray of the affected joint** \>\> often will show one or more typical features of OA * **For hip** \>\>\> Do *_non-weight beraing_*_X-ray pelvis PA view_ * **For knee** \>\>\> Do *_stan_**_ding_*_X__-ray knee AP view_ \>\>\> to assess \>\>\> tibio-femoral cartilage loss * A _flexed skyline view_ \>\>\> to assess patello-femoral involvement. * **For spine** \>\>\> _Plain X-ray spine_ * If suspected spinal stenosis or nerve root compression \>\>\> _Do MRI_ * Routine biochemistry: normal * CBC/haematology: normal * Autoantibody tests: usually normal * Acute phase response: moderate * Synovial fluid (aspirated from an affected joint) * _viscous_ * _A low cell count_
54
Importance of plain x-ray in OA
**Importance:** It is of value in **assessing the severity of structural change** \>\>\> which is _helpful if joint replacement surgery is being considered._
55
Probable X-ray findings in hand OA
In hand: * **Joint space narrowing** affecting the **_PIP and DIP_** * In some OA-affected joints \>\>\> typical \> **Articular subchondral and ‘gullwing’ appearances** * **Osteophyte formation**
56
Probable X-ray findings in knee OA
In knee: * **Advanced OA** \>\>\> _almost_ _complete loss of joint space_ \>\>\> *affecting both compartments* * _Sclerosis of subchondral bone_ * **In severe patello-femoral OA** \>\>\> _almost complete loss of joint space_ + _lateral displacement of the patella_ * **If marked medial tibio-femoral OA** \>\>\>\>\> typical _varus_ knee deformity
57
Probable X-ray findings in hip OA
**In hip:** * Superior joint space narrowing * Subchondral sclerosis * Osteophytes * Cysts
58
Probable X-ray findings in spine OA
**In spine:** * Disc narrowing * Osteophytes * Osteosclerosis *_at the apophyseal joints_* * Cervical spondylosis
59
Unexplained early onset OA \>\>\> investigations
* If unexplained early-onset OA \>\>\> **Do additional investigation**: _Guided by the suspected underlying condition._ * **In acromegaly** \>\>\> X-ray shows: * Dysplasia or * Vascular necrosis * _Widening_ of joint spaces * **In haemochromatosis** \>\>\> X-ray shows * Multiple cysts * Chondrocalcinosis * _MCP joint_ involvement in haemochromatosis * **In neuropathic joints** \>\>\> X-ray shows * Disorganised architecture
60
Rheumatoid arthritis: what is it?
* A common form of **inflammatory arthritis** * It occurs **throughout the world** and in **all ethnic groups** * **Chronic disease** * Characterised by a ***_clinical course of exacerbations and remissions_*** * _A complex disease \>\>\> both genetic and environmental components_
61
Rheumatoid arthritis \>\>\> epidemiology
* **Age:** Peak onset = _30-50_ years, _although occurs in all age groups_ * **Sex:** Female: Male ratio = _3:1_ (_Female has more_ ratio than male) * **Prevalence in the UK** = _1%_ (= 1 in 100 = 1000 in 100,000) * **Prevalence in Europe & in the Indian subcontinent** = _0.8-1.0%_ * **Prevalence in the south-east Asia** = _0.4% (lower)_ * **Prevalence in Pima Indians** = _5% (highest in the world)_ * Some ethnic differences e.g. *_High in Native Americans_*
62
RA \>\>\> pathophysiological chart
63
RA \>\>\> HLA association
**HLA-DR4** (especially _Felty’s syndrome_) The strongest association is with variants in the HLA region. Recent studies have shown that \>\>\> the association with HLA is determined by \>\>\> * Variations in 3 amino acids in the _HLA-DRβ1 molecule_ *(positions 11, 71 and 74)* * _Single variants HLA-B_ *(at position 9)* * _HLA-DPβ1_ *(at position 9)* The non-HLA loci generally lie within or close to genes involved in regulating the immune response.
64
RA \>\>\> key factor in pathophysiology
**TNF (Tumour necrosis factor)** ## Footnote *So, anti-TNF is given in RA treatment*
65
RA \>\>\> genetic factors
The importance of genetic factors is demonstrated by \>\>\> * **H****igher concordance**of RA in ***_monozygotic (12–15%)_*** compared with *_dizygotic twins (3%)_* * **increased frequency** of disease in the **first-degree relatives** * _Nearly 100 loci_ *that are associated with the risk of developing RA (detected by genome wide association studies)*
66
RA \>\>\> environmental factors/trigger
* **Infection** * In a _genetically susceptible host_ \>\>\> through processes like _citrullination_ \>\>\> _modify host proteins_ \>\>\> _triggers autoimmunity_ \>\>\> becomes immunogenic * NO single specific pathogen has been identified * **Cigaretter smoking** * Associated with *_more severe disease_* * *_Reduced responsiveness to treatment_*
67
RA \>\>\> pathophysiology
* **infiltration of the synovial membrane with \>\>\>** * CD4+ T -lymphocytes *(interacts with other cells of the synovium)* * B lymphocytes *(interacts with other cells of the synovium)* * Plasma cells * Dendritic cells * Macrophages * \>\>\> **Lymphoid follicles form within the synovial membrane** \>\>\> in which T- and B-cell interactions occur \>\>\> causing \> 1. Activation of T cells \>\>\> to produce _cytokines (+)_ 2. Activation of B cells \>\>\> to produce _autoantibodies, (including RF and ACPA)_ * **The** **Positive feedback loop:** * T cells produce _TNF_ and _interferon gamma (IFN-γ)_ \>\>\> they activate synovial macrophages * Macrophages produce several _pro-inflammatory_ _cytokines_, including \>\>\> _TNF, IL-1 and IL-6_ \>\>\> which act on synovial fibroblasts \>\> produce further cytokines \>\>\> set up a positive feedback loop * **Synovial fibroblasts proliferate,** causing \>\>\> synovial hypertrophy \>\>\> producing _matrix metalloproteinases +_ _the proteinase ADAMTS-5_ \>\>\> which degrade soft tissues and cartilage. * **Within ithe inflammed** **synovium** \>\>\> _Prostaglandins and nitric oxide_ produced \>\>\> cause \> vasodilatation \>\> swelling + pain. * **Systemic release of _IL-6_** triggers production of acute phase proteins by the liver. * **At the joint margin** \>\>\> the inflamed synovium (pannus) \>\>\> directly invades bone and cartilage \>\> cause joint erosions. * A **key pathogenic factor in bone erosions and** **periarticular osteoporosis** is osteoclast activation, stimulated by \<\<\< * the production of _M-CSF by synovial cells_ and _RANKL by activated_ _T cells_ * New blood-vessel formation (**angiogenesis)** **occurs** \>\>\> causing \> the inflamed synovium to become \>\>\> highly vascular * Within these blood vessels \>\>\> pro-inflammatory cytokines \>\>\> activate endothelial cells \>\>\> support recruitment of yet more leucocytes \>\>\> perpetuate the inflammatory process. * **Later,** fibrous or bony ankylosis may occur. * **Adjacent miscles to inflamed joints** \>\>\> atrophy + (may be) infiltrated with lymphocytes \>\>\> leads to \>\>\> progressive biomechanical dysfunction \>\>\> may further amplify destruction * **Rheumatoid nodules** occur in patients _who are RF or ACPA_ _positive_ \>\>\> primarily affect extensor tendons. * They consist of \>\>\> * A central area of fibrinoid material * Surrounded by a palisade of proliferating mononuclear cells. * **Granulomatous lesions** may occur in \>\>\> the pleura, lung, pericardium and sclera.
68
Rheumatoid arthritis \>\>\> Commonly affected joints
* Small joints of the hands **_(PIP, MCP)_** * **_Feet_** and **_wrists_** * **_Large joints_** * ***Symmetrical involvement (= arthritis)***
69
Rheumatoid arthritis \>\>\> Features of the affected joints
* Pain * Joint _swelling_ _(_*commonly* _of PIP, MCP or wrist joints)_ * Soft tissue _swelling_ * Morning stiffness \>1 hour
70
RA \>\>\> examination of the joints typically reveals - ?
* Swelling * Tenderness * *Erythema is unusual* *_(Erythema suggests Co-existent sepsis)_*
71
Sometimes RA has \>\>\> an _acute_ onset + _severe_ early morning stiffness + _polyarthritis_ + _pitting oedema._ This occurs more commonly in - ???
Older age
72
RA \>\>\> Muscle-related another presentation
**“Proximal muscle stiffness”** mimicking \>\>\> *_polymyalgia rheumatica_*
73
Risk factor (micriorganism) of RA
**Proteus mirabilis** is a _(G-ve rod)_, causes **UTI** → *predisposes susceptible patients to RA*
74
RA \>\> time course (acute/chronic/intermittent)
* It is M**ainly chronic** disease * *Sometimes* RA has \>\>\> An acute onset + severe early morning stiffness + polyarthritis + pitting oedema. (This occurs more commonly in old age) * *Occasionally* \>\>\> the onset is palindromic + with relapsing and remitting episodes of pain, stiffness and swelling (that last for only a few hours or days)
75
RA \>\>\> hand deformities ## Footnote (when and what)
**When they develop:** _Long-standing uncontrolled_ disease in _older people_ *Although these have become less common over recent years with more aggressive management in young age* * **Ulnar deviation** *of the fingers* * **Swan neck** _deformity_ * **Boutonnière or ‘button hole’** _deformity_ * **Z** _deformity_ *of the thumb* * _Dorsal subluxation of the ulna_ *at the distal radio-ulnar joint* (may be) \>\>\> contribute to **Rupture of the fourth and fifth extensor tendons.** * If _nodules_ in the *flexor tendon sheaths* \>\>\> **Triggering of fingers**
76
RA \>\>\> lower limb deformities ## Footnote (when and what)
* *When they develop:** _Long-standing_ _uncontrolled disease_ in _older people_ * Although these have become less common over recent years with more aggressive management in the young age* * **Subluxation of the MTP joints** *(meta-tarso-phalangeal joints) of the feet* \>\>\> (may result) in **‘cock-up’ toe** deformities, causing: * **Pain on weight-bearing** _on *the exposed MTP heads*_ * Development of **secondary adventitious bursae and callosities** * *_In the hind foot_* \>\>\> **damage to the ankle and subtalar joints** \>\>\> **valgus** deformity o**f the calcaneus** * Associated with **loss of the longitudinal arch (flat foot)** \<\<\< **due to rupture of the tibialis posterior tendon** * *In patients with _knee synovitis_* \>\>\> **Popliteal (Baker’s) cysts** may occur * Here, synovial fluid communicates with the cyst but is prevented from returning to the joint by a valve-like mechanism (NOT specific to RA) * _Rupture may be induced by knee flexion \>\>\> leading to \>\> calf pain + swelling \>\>\> may mimic a deep venous thrombosis (DVT)._
77
More commonly, involved joints in RA, OA, PA
* PIP, MCP, Wrist \>\>\> Rheumatoid arthritis * DIP \>\>\> Osteoarthritis, Psoriatic arthritis * Base of the thumb \>\>\> Osteoarthritis
78
Which patient group should be checked by ACR criteria of RA?
Target population: 1. Patient with **At least 1 joint with clinical synovitis** 2. Patient with **synovitis**, **_not explained by any other disease_**
79
ACR (2010) criteria for diagnosis of Rheumatoid arthritis
**Diagnosis by scale:** * Add score of categories A to D: If score ≥ 6/10 \>\>\> Dx: Rheumatoid arthritis * *For not missing any criteria \>\>\> Check through the criteria (from high score to low score) (= 5 to 0, 3 to 0, 1 to 0)*
80
Systemic complications of rheumatoid arthritis
* Fever * Susceptibility to infection * Weight loss * Fatigue * Anorexia
81
RA \>\>\> Respiratory complications
*(above downwards)* * Bronchiolitis obliterans * Pulmonary fibrosis → *often _asymptomatic_; sometimes, risk is increased by _anti-TNF therapy_* * Pulmonary nodules * Methotrexate pneumonitis (A complication of drug therapy) * Fibrosing alveolitis * Pleural effusion * Pleurisy * Caplan's syndrome \>\>\> massive fibrotic nodules (= pneumoconiosis) (due to occupational coal dust exposure) * Infection (possibly atypical) secondary to immunosuppression
82
RA \>\>\> Cardiac complications
RA patients have an increased risk of IHD * IHD (Ischaemic Heart Disease) *(more common)* * Pericarditis * Myocarditis * Endocarditis * Conduction defects * Coronary vasculitis * Granulomatous aortitis * Rare: heart block, cardiomyopathy, coronary artery occlusion, aortic regurgitation
83
RA \>\>\> Neurological complications
* Cervical cord _compression_ * _Compression neuropathies_ * Peripheral _neuropathy_ * Mononeuritis multiplex
84
RA \>\>\> Psychiatric complication
Depression
85
RA \>\>\> ocular complications
Fron to back * **Keratoconjunctivitis sicca *(most common)*** → _d__ry, burning, gritty eyes_ * Cause: Secondary Sjogren’s syndrome * **Episcleritis** → redness * **Scleritis** → redness + pain → *uncommon, but most serious sight-threatening* * If so → urgent refer to ophthalmology, artificial tear, antibiotics * **Keratitis** (peripheral ulcerative keratitis) → redness + pain → uncommon, but most serious sight-threatening * **Corneal ulceration** * **Steroid-induced cataracts** * **Scleromalacia** * **Chloroquine retinopathy**
86
RA \>\>\> musculoskleletal complications
* **Osteoporosis (more common)** * Muscle-wasting *(Cause:* *systemic inflammation + reduced activity)* * Tenosynovitis * Bursitis
87
RA \>\>\> vasculitis related complications
* Digital _arteritis_ * Visceral _arteritis_ * *Ulcers* * *Pyoderma gangrenosum* * Mononeuritis multiplex
88
RA \>\>\> Haematological complications
* Anaemia *_(Due to NSAID induced GI blood loss → iron deficiency → microcytic anaemia)_* * Thrombocytosis * Eosinophilia * **In active disease → normochromic normocytic anaemia + thrombocytosis**
89
RA \>\>\> lymphatic complications
* **Felty's syndrome** (*_RA + splenomegaly + low white cell count/ neutropaenia)_* * **Splenomegaly** * **Localised or generalised lymphadenopathy** can occur in patients with _active disease_ * But **persistent lymphadenopathy** → may indicate \>\>\> the _development of lymphoma_ \>\>\> more common in _long-standing RA_
90
RA \>\>\> nodules
* **Subcutaneous nodules** * Sinuses * Fistula
91
RA \>\>\> a less common but important complication (mainly in poorly controlled RA)
Amyloidosis
92
Extra-articular features are more common in - ?
* Patient with **_long-standing_ _seropositive_ _erosive_ disease** * *Occasionally.* They can occur *_At presentation (especially In men)_* * ***Most are due to*** * ***_Serositis_*** * ***_Granuloma_*** * ***_Nodule formation_*** * ***_Vasculitis_***
93
Subcutaneous nodules of RA occur in -?
Almost exclusively in RF or ACPA positive patients
94
Subcutaneous nodules of RA \>\> usual site ?
Extensor tendons
95
Subcutaneous nodules of RA \>\>\> symptomatology
* *Frequently* **asymptomatic** * *_Some_ may be complicated by \>\>\>* **ulceration and secondary infection**
96
Vasculitis in RA \>\>\> features
This is *uncommon* but *may occur in **seropositive patients.*** **The presentation is with →** * **systemic symptoms, such as** * fatigue * fever * nail-fold infarcts * **Rarely,** * cutaneous ulceration * skin necrosis * mesenteric, renal or coronary artery occlusion (may occur)
97
Risk of CVS disease in RA is increased due to - ?
A combination of \>\>\> conventional risk factors, such as: * High cholesterol * Smoking * High BP (HTN) * Low physical activity * _NSAIDs_ * _Glucocorticoids_ * *The effects of inflammatory cytokines on vascular endothelium*
98
RA \>\>\> frequency of cervical cord compression
Rare
99
Cause of cervical cord compression in RA
Subluxation of the cervical spine
100
RA \>\>\> level of cervical cord compression
At the _atlanto-axial joint_ or at _subaxial level_
101
RA \>\>\> course of cervical cord compression in RA
Course: Due to **erosion of the transverse ligament** *_posterior to the odontoid peg._* \>\> **atlanto-axial subluxation** →can lead to \>\>\> **cord compression** OR ***_following minor trauma/manipulation → sudden death_***
102
RA \>\>\> cervical cord compression: clinical features
* Suspect if – **paraesthesia or electric shock in the arms** * **Insidious onset** * **Subtle loss of function**→ may _initially be attributed to active disease_ ## Footnote In patients with _extensive joint disease_ → _reflexes and power can be difficult to assess; *Therefore, sensory and upper motor signs are most important*_
103
RA \>\>\> cervical cord compression: TOC ?
Urgently refer to neurosurgery → stabilisation and fixation
104
Rheumatoid arthritis: \>\>\> Cause of Compression or entrapment neuropathy
Hypertrophied synovium or Joint subluxation
105
RA \>\>\> Examples of compression/ entrapment neuropathy
* *The most common:** median nerve compression → present as: bilateral carpal tunnel syndrome * *others:** ulnar nerve (at elbow or wrist), lateral popliteal nerve (at fibular head)
106
Tarsal tunnel syndrome in RA
Entrapment of **posterior tibial nerve** in the _flexor retinaculum_ → tarsal tunnel syndrome → *_burning, tingling and numbness*_ in the _*distal soles and toes_*
107
Serositis in RA
* ***_Asymptomatic;_*** *but may be –* * **Pleural pain** * **Pericardial pain** * **Breathlessness** * *Pericardial effusion (rare)* * *Constrictive pericarditis (rare)*
108
When does amyloidosis occur in RA?
If RA is poorly controlled
109
Amyloidosis \>\>\> common features and findings
* _Albumin:_ very low * _Creatinine:_ high * **_Protein_**uria (may be as nephrotic syndrome) * Hepatomegaly * Small joint Arthropathy * *Fatigue* * *Weight loss* * _Peripheral_ oedema * _Peripheral_ neuropathy
110
Secondary amyloid - \>\> ?
_*Extracellular* accumulation_ of **AA fibrils** _within tissue and organs_ (due to **acute phase reactant, serum amyloid A)**
111
Felty's syndrome \>\>\> risk factors
* **Age of onset:** _50-70_years * **Sex:** _Female_ \> Male * **Race:** _Caucasians_ \> Black * **Long standing RA** * **Deforming** + but **inactive disease** * **RF seropositive**
112
Felty's syndrome \>\>\> common C/F
* **_Splenomegaly (MAIN)_** * **_Lymphadenopathy_** * *_Weight loss_* * _Skin pigmentation_ * _Keratoconjunctivitis sicca_ * *Vasculitis, leg ulcers* * *Recurrent infections* * *Nodules*
113
Felty's syndrome \>\>\> lab findings
* Normochromic, normocytic anaemia *(Like active RA)* * Neutropenia (MAIN) * Thrombocytopenia * Impaired T- and B-cell immunity * Abnormal liver function
114
RA \>\>\> IOC ?
Anti-CCP antibodies (= Anti-cyclic citrullinated peptide antibody = ACPA)
115
If suspected RA + but, rheumatoid factor negative \>\>\> what next ? (NICE recommendation)
test for anti-CCP antibodies → if it’s positive → Dx: RA
116
RA \>\>\> top 3 main investigations
* **IOC:** Anti-CCP antibodies (= Anti-cyclic citrullinated peptide antibody = ACPA) * Rheumatoid factor (RF) * NICE recommendation: If suspected RA + but, rheumatoid factor negative → test for anti-CCP antibodies → if it’s positive → Dx: RA * X-ray of the joints
117
Ra \>\>\> investigations to establish diagnosis
* Clinical criteria * ESR and CRP → raised *(but normal level do NOT exclude RA, especially if few joints are involved)* * USG or MRI * Not routinely required * *_Indication:_* _clinical uncertainty about the presence of →synovitis_ * Anti-CCP (NICE recommended IOC) * RF
118
To monitor disease activity and drug efficacy in RA - ?
* Pain (visual analogue scale) * Early morning stiffness (minutes) * _Joint_ tenderness * _Joint_ swelling * *DAS28 score* * *_ESR_* * *_CRP_*
119
To monitor disease damage in RA - ?
* X-rays * Functional assessment
120
To monitor drug safety in RA - ?
* FBC (Full blood count) * Urine R/E (Urinalysis) * Urea and creatinine * Liver function tests (LFT) * Chest X-ray
121
Anti- CCP antibodies (ACPA) \>\>\> sensitivity and specificity
* Sensitivity = 70-80% (similar to RF) * Means, among the ‘Patients with RA’ → ACPA & RF can detect 70-80% of them * Specificity = 90-95% (higher than RF)
122
Anti- CCP antibodies (ACPA) for detection of future development of RA
* Detectable up to 10 years before the development of RA * Play a key role in the future RA → allows early detection of patients \>\>\> suitable for “aggressive anti-TNF therapy”.
123
What is RF (Rheumatoid factor) ?
Circulating Ab (usually IgM) which reacts with Fc portion of patient’s own IgG
124
Methods of testing RF (Rheumatoid factor)
* Rose-waaler test: → sharp red cell agglutination * Latex agglutination
125
RF \>\>\> sensitivity and specificity to detect RA
* Sensitivity: 70% (these are also positive for ACPA) * Less specific than ACPA
126
Dseases where RF is positive
* Rheumatoid arthritis (70%) * Sjogren’s syndrome (100%) * Felty’s syndrome (100%) * Infective endocarditis (50%) * SLE (20-30%) * Systemic sclerosis (30%) * General population: 5% * Rarely: TB, leprosy, HBV, EBV
127
X-ray findings in early RA
* Loss of joint space *(seen in both RA and osteoarthritis)* * Juxta-articular osteoporosis * Soft-tissue swelling * Usually normal hand, wrist, feet
128
X-ray findings in late/advanced RA
* Periarticular erosions (osteopenia and osteoporosis) (periarticular osteoporosis and marginal joint erosions) * Subluxation of joint
129
The main indication of X-ray in rheumatoid arthrits
Assessment of → **painful joints** → to determine \>\>\> if any _significant structural damage_
130
In RA, if suspected atlantao-axial disease \>\>\> investigations
Lateral X-rays (taken in flexion and extension) + MRI
131
In RA, if suspected Baker's cyst \>\>\> investigation
Ultrasound (may require)
132
Purpose of DAS28 scoring in RA
To assess \>\>\> the need of: * Disease activity * Response to treatment * Need for biological therapy
133
How is DAS28 scored and interpreted?
Count **_“the number”_** of **_“swollen and tender joints”_** in the _upper limbs and knees_ \>\>\> combine this with \>\>\> the _ESR_ **+** the _patient’s assessment of the activity of their arthritis_ *(on a visual analogue scale**: where, 0 indicates no symptoms and 100 the worst symptoms possible)* → enter into a calculator *(online)* → generate a numerical score. **Interpretation:** The higher the value → the more active the disease
134
Change of RA during pregnancy
* **Old prior diagnosed RA** _improves (may remission)_ in pregnancy * Often has a _flare after delivery_ (or _often first presents post-partum)_ * *Why:** *_immunosuppression in pregnancy + hormonal changes_*
135
RA & conception or future pregnancy
* **If early RA or poorly controlled (= unstable)** **RA**→ defer conception until disease is stable * **Stop methotrexate _(at least) 3 months before_ pregnancy** * **Stop Leflunomide _(at least) 24 months before_ pregnancy**
136
RA in pregnancy \>\>\> use of Analgesic
* **Analgesic of choice:** Paracetamol * **Contraindicated** → _NSAIDs_ * NSAIDs & selective COX-2 inhibitors → can be used _up to 32weeks_ of pregnancy *(Davidson says _upto*_ _*20 weeks_)* * _NASIDs can cause early closure of ductus arteriosus_
137
RA is pregnancy \>\>\> use of glucocorticoids
* Can be used **to control disease flares** * **Risks of:** *_Hypertension, glucose intolerance, osteoporosis_* * *Short-term glucocorticoids is safe in lower dose in pregnancy* * *If needed* → **TOC:** **Low –dose prednisolone**
138
DMARDs that are safe (can be used) in RA + pregnancy
* Sulfasalazine _(1st line)_ * Hydroxychloroquine (_1st line)_ * Azathioprine _(2nd line)_ ## Footnote **SHA**
139
RA in pregnancy \>\>\> DMARDs that are contraindicated (must be avoided
* Methotrexate *(also C.I in breast-feeding)* * Leflunomide *(also C.I in breast-feeding)* * Cyclophosphamide *(also C.I in breast-feeding)* * Mycophenolate * Gold
140
RA in pregnancy \>\>\> biological therapies
* *Limited experience* * *May be _relatively safe_ during pregnancy* * **The main theoretical risk** → _immunosuppression in the neonate_ * *Except for** → **_Certolizumab_** → *_crosses the placenta in negligible amounts._*
141
RA in pregnancy \>\>\> treatment outline
* **First line:** Sulfasalazine or Hydroxychloroquine (Safe in pregnancy) * **Second line:** Azathioprine (If first line fails to control * Before Azathioprine → check TMPT deficiency * **Oral analgesic of choice** in pregnancy: Paracetamol * Short-term glucocorticoids (Low –dose prednisolone) is safe in lower dose in pregnancy * In obstetric anaesthesia of RA patient → check the risks of atlanto-axial subluxation
142
Breast-feeding \>\>\> anti-RA drugs that are contraindicated
* Methotrexate * Leflunomide * Cyclophosphamide
143